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Abstract
The Effect of Interspecies Signaling on Stenotrophomonas maltophilia Growth
Zachary Dickinson
May 2016
Cystic fibrosis (CF) is a genetic disorder that effects over 70,000 people worldwide, and
is particularly prevalent in those of Caucasian descent. CF increases susceptibility to chronic
infections of the lungs and GI tract, often leading to decreased quality of life and early death to
afflicted individuals. No cure is available, and so treatment is limited to treating the frequent
infections that afflict CF patients. Several species of bacteria are commonly implicated in these
infections, including Stenotrophomonas maltophilia. Infections of this species is of particular
interest as it has been shown to be highly antibiotic resistant. This is a concern when it is part of
coinfections with other, more virulent species, such as Pseudomonas aeruginosa. It has been
shown that these two species are much more difficult to treat when they are present together than
either one is alone.
There is thought to be a molecular signaling mechanism through which these two species
are able to communicate and increase each other’s resilience, although the exact identity of that
mechanism is unknown. This study began by identifying (based on bioinformatics) six likely
candidates for quorum sensing receptor proteins. Through insertional interruption, five of these
genes were made nonfunctional and these constructs were tested to identify a growth phenotype
of S. maltophilia in the presence and absence of P. aeruginosa. Results of this study may suggest
that none of the selected gene products play a role in communication between these two species,
but additional assays may identify a connection.
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Introduction and Background:
Stenotrophomonas maltophilia is a species of gram-negative, nonfermentive bacteria that
is not generally pathogenic to healthy humans(2). S. maltophilia is able to colonize a large variety
of environmental habitats including soils, fluid media, and the surfaces of plants (3). It general, S.
maltophilia is unable to infect human hosts because it is unable to easily bypass the basic
immune defenses(3). In spite of this, S. maltophilia has been gaining increased attention as an
emerging pathogen in the past two decades for a number of reasons, especially in hospital
settings(2,6, 8, 10). S. maltophilia has been shown to be highly resistant to a suite of antibiotics,
including quinones, β-lactams (carbapenems, penicillins, cephalosporins) and
aminoglycosides(3). Additionally, S. maltophilia is able to colonize plastic surfaces (as a result of
adaptations that include a positively charged surface and fimbrial adhesions). As a result, it is
now commonly found on a variety of common medical equipment, including catheters,
endotracheal tubes, and other indwelling-lines that aid in the bacteria’s transmission into its
host(3). Once entry into the a host has been established, S. maltophilia infection primarily results
in pneumonia, but bloodstream infections (septicemia), infection on the skin and soft tissues,
urinary tract infections, intraabdominal infections, and even ocular infections can also occur(8).
S. maltophilia infections occur most frequently in immunocompromised and chronically
ill patients(2) and are of particular concern for patients with cystic fibrosis (CF). Cystic fibrosis is
the most prevalent genetic disorder among people of European descent (9). As a genetic disorder,
cystic fibrosis is a result of mutations in the gene encoding the Cystic Fibrosis Transmembrane
Conductance Regulator (CFTR)(1). Most often (in about 71% of patients with CF), the
dysfunction is caused by a deletion of the phenylalanine codon 508 in the CTFR gene (9). CTFR
functions as a chloride transporter and is a critical component of maintaining proper
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chemiosmotic balances across cellular membranes(9). As such, this protein is critical in the
production of sweat, digestive fluids, and mucus. Individuals born with a faulty copy of CTFR
from each parent are unable to produce normal secretions.
The inability to maintain chemiosmotic balance is especially problematic for the
secretions in the lungs. In healthy individuals, the lungs secrete a thin lubricant. Any foreign
material, such as dust or potential pathogens, is caught in this secretions and the cilia lining the
epithelia of the lungs can easily clear this secretion, bringing it to the back of the throat where it
can be coughed up or swallowed. Since CF patients do not maintain the proper balance of
extracellular ions, the volume of pericellular fluid is drastically reduced and mucus clearance is
severely hindered(1). This creates a warm, humid environment that is created is ideal for
colonization by bacteria, setting up CF patients for chronic infections in the lungs (1).
Historically, CF was a deadly condition that resulted in severely shortened life
expectancies of afflicted individuals (7). This was due primarily to chronic infections of the
respiratory tract that would eventually cause a severe decline in lung function and lung failure.
This process begins as an inflammatory response to the growing populations of bacteria in the
lungs. The body attempts to mount a defense, leading to a chronic neutrophil-dominated
infection and persistent inflammatory response resulting in tissue necrosis and tissue scarring
that prevents gas exchange in respiration (7). This decline continues until the patient receives a
transplant of a healthy lung or lung function degrades sufficiently enough as to cause death. In
recent decades, thanks to the advent of advancing aggressive antibiotic therapies, individuals
with CF are living well beyond their forties, whereas before they often did not survive childhood.
Even with antimicrobial therapies, the main problem for CF patients is the chronic inflammatory
state that results from persistent infections. With preemptive and aggressive antibiotic treatment,
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these chronic infections take longer to develop, and the resultant tissue necrosis occurs much
later in life. As a result, quality of life for CF patients is greatly improved and life expectancy
has increased by decades(7).
As CF patients are increasingly able to live well into adulthood, the complications that
arise from persistent antibiotic use are becoming clearer. As CF patients age, they begin to
acquire bacteria not so easily cleared by many front-line antibiotics. These bacteria include
Stenotrophomonas maltophilia, Pseudomonas aeruginosa, Staphylococcus aureus, Haemophilus
influenzae, Burkholderia cepacia, Achromobacter xylosoxidans, and Prevotella intermedia (1).
The most concerning of these is also the most common: Pseudomonas aeruginosa. In adults, P.
aeruginosa will colonize various portions of the conducting and respiratory zones of the
respiratory tract, and if not treated can lead to the chronic infection state described above (1). The
presence of multi-antibiotic resistant P. aeruginosa is a marker of advanced disease requiring
extensive antibiotic therapy (1). However, treatment for this bacteria exists in the form of
aggressive mixes of intravenous, oral, and inhaled antibiotics (1). If caught and treated early
enough, the infection can be kept from developing into a serious, life-threatening state.
Current research involves attempts to identify more effective treatments for the advanced
stages of chronic bacterial infections. These studies have shown that the presence of biofilms
increases the complexity of treating such infections. Biofilms are a community of microbial
organisms (either one or multiple species of bacteria) that inhabit a favorable growing
environment such as an extracellular mucus (in the case of biofilms for cystic fibrosis patients)
but also including nonorganic environments such as rocks(3). The exact mechanism that
facilitates biofilm creation and adhesion is not well understood for most species(5). However, it is
understood that the physical structure of the biofilm (which often exists as an extracellular matrix
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or slime layer secreted by the organisms) creates an environment that is both ideal for bacterial
growth and adaptation while simultaneously severely hindering the effectiveness of antibiotic
treatment(3). As an exacerbating factor, these biofilms have been shown to be ideal habitats
promoting colonization by multiple species of bacteria, including many of those listed above(1).
Participation in biofilm communities by S. maltophilia is particularly problematic. Likely
thanks to its origin in soil and aquatic ecosystems, S. maltophilia contains a diverse set of
adaptations suited to hostile environments. These adaptations include an intrinsic high level of
resistance to multiple antibiotics, the ability to utilize horizontal gene transfer, and a suite of
efflux pumps that constitutively pump out harmful chemicals (11). Although S. maltophilia is not
extraordinarily virulent, the frequency of isolation of S. maltophilia from chronically ill patients
and compromised patients (including CF patients) is on the rise thanks in part due to improved
detection methods(2) and more effective antibiotic treatment. Consequently, its natural resistance
has become a concern. S. maltophilia could potentially act as a reservoir for resistance that could
be passed on to more pathogenic organisms, such as P. aeruginosa(11).
As the role of S. maltophilia in chronic infections emerges, the rates of its coinfections
with P. aeruginosa and their possible synergism becomes an important topic of study. A study
on biofilm formation between P. aeruginosa and S. maltophilia on in vitro IB3-1 cells (lung
epithelial tissue) showed that, once a biofilm is created by P. aeruginosa, S. maltophilia is more
readily able to adhere and colonize that biofilm (4). A biofilm containing multiple species is of
concern, as it imposes greater challenges to conventional treatments(7), although again the exact
etiology of this challenge has not been well understood. Furthermore, for CF patients in
particular there is concern about coinfections, as the presence of S. maltophilia has been shown
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to disrupt ion concentrations, which would further exacerbate the chemiosmotic problems
resulting from the faulty CFTR(6).
Although the specific nature of the effectors resulting in synergism between bacteria that
makes the multi-species biofilms so robust are not fully understood, intercellular signaling is
expected to be involved(5,7). Quorum sensing could play a role, as it is known to play an
important role in the virulence of P. aeruginosa(14) P. aeruginosa uses three different types of
signaling systems (for quorum sensing) to communicate with itself as well as other species. The
first two use acylated homoserine lactones (AHLs) that use two different receptor proteins: Las
and Rhl(16). A third signaling system uses molecules belonging to the 2-alkyl-4-quinolone family
(often referred to as PQS, or Pseudomonas quinolone signal) and is known to bind a response
effector (pqsE)(15,16). Additionally, various strains of P. aeruginosa have been shown to secrete a
suite of other compounds that may have signaling capabilities including pyocyanins, which,
while they have inhibitory effects at high concentrations, have been shown to modulate gene
regulation in lower concentrations(16). As a result, this species is able to sense and respond
appropriately to its own cell density as well as the composition of other species in its
environment. Since S. maltophilia is a member of the γ-proteobacteria like P. aeruginosa and is
likely responding to signals produced by P. aeruginosa, it is highly probable that it uses
receptors similar to those produced by P. aeruginosa. Additionally, S. maltophilia is capable of
horizontal gene transfer, which could possibly play a role in increasing the resistance of adjacent
species(7). Ultimately, there must be a mechanism behind the synergistic behavior of these
species, although the area is understudied (7).
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Specific Aims
Initial computer genome mapping of S. maltophilia’s genome of the K279a strain has
identified two genes, rpfG and Smlt_0278, as encoding quorum sensing proteins(11). Further
bioinformatics analysis identified Smlt_0184, Smlt_1432, Smlt_1839, and Smlt_3567 as
additional strong candidates to encode other quorum sensing proteins through their high
similarity to known receptors. The purpose of this study was to determine, through insertional
interruption (using the plasmid vector pEX18Tc), if these genes have any significant effect on
the growth of S. maltophilia both with and without the presence of P. aeruginosa.
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Methodology:
PCR Optimization
Primers binding to internal sites in each of the six genes were purchased from Integrated
DNA Technologies (Coralville, Iowa). These primers were designed to amplify an internal ~500
bp fragment of each gene. This fragment, when cloned into pEX18Tc (which is not expected to

Figure 1: Summary of amplification, ligation, and insertion events.
be able to replicate in K279a(13)) would result in interruption of the desired gene due to single
crossover of the plasmid into the genome. This would occur because the internal fragment
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contains neither the start nor the stop of the gene, so neither gene fragment resulting from the
recombination would result in a functional protein (Figure 1).
The primers were based upon the genome sequence of the S. maltophilia strain K279a, in
which the transmembrane receptors were identified(11). A summary of the genes, including the
expected size of the product and the sequence of the primers, is provided in Table 1.
Table 1: Summary of the genes and the primers used to amplify them.
Gene
Expected Product Reverse Primer
Forward Primer
Size (bp)
rpfG

645

5′–GCG GGA TCC CCT GGT
GCG AGG CGC ACC C–3′

Smlt_0184

366

5′–GCG GGA TCC TAA GGC
GGC GAC GCC GAC GGC–3′

Smlt_0278

628

Smlt_1432

421

Smlt_1839

567

Smlt_3567

715

5′–GCG GGA TCC TAA GGA
AGA CTC GCG CGCC GCT–3
′
5′ – GCG GGA TCC CCA
TCG CGG CAC GGT AGG G –
3′
5′ – GCG GGA TCC GTT
CTC CAC CGT GCG CGT GG –
3′
5’ GCG GGA TCC TAA GCG
GCA GAC TGC GGT GAT GG
– 3′

5′–GCG GAA TTC CGC
GCT TCC AGC GGG ATC G–
3′
5′–GCG GAA TTC TTA
CAC GGC CAT AGA ACT
CGC CG–3′
5′–GCG GAA TTC TTA
GCC AAG CAG TTC CTG
CAG ATC–3′
5′- GCG GAA TTC CGC
CAC CAT TGC GAC CGC G 3′
5′- GCG GAA TTC GGT
CCT GCG AGG CAT CGC G –
3′
5′ - GCG GAA TTC TTA
GCC GAT CGC GGC CTG
CAC G -3′

Multiple PCR conditions were tested in order to determine those resulting in the best
amplification of the desired products. To this effect, the polymerases Phusion (New England
Biolabs(NEB), Ipswich, MA), HotStar (Qiagen, Hilden, Germany), and GoTaq green (Promega,
Madison, Wisconsin) were used. Gel electrophoresis was performed after each trial. A 2 log
DNA ladder (NEB) was used as size comparison in order to determine if desired gene products
were amplified correctly. Table 2 outlines the conditions that were used.
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Table 2: Basic PCR cycling used for the majority of PCR reactions.
Step #

Temp (Degrees Celsius)

Time (min:sec)

1

95

5:00

2

95

0:30

3

55

1:00

4

72

2:00

5

Go to step two 35 times.

6

72

10:00

7

4

hold

GoTaq Green
PCR mixes with GoTaq green were made with 5 µl of GoTaq Green mix, 1 µl each of the
desired product’s 20 pM forward and reverse primer, 1 μl approximately 200 ng/µl
phenol/chloroform-purified K279a genomic DNA that had been previously obtained by other
researchers, and 2 µl of water to bring the entire solution to 10 µl.
HotStar
Each PCR mix prepared with HotStar as a polymerase were comprised of 1 µl of HotStar
polymerase, 10 µl of HotStar 5× Buffer, and 10 µl of Q buffer. To this, 1 µl each of the 20 pM
forward and reverse primer of desired amplification product was added. 1 µl of ~200 ng/μl
K279a genomic DNA was added and 24 µl of water to bring the entire solution to 50 µL.
Phusion
Phusion PCR mixes were comprised of 0.5 µl of Phusion, 10 µl of Phusion 5× buffer Hi
GC, and 10 µl (10 mM) dNTPs. To this, 1 µl each of the 20 pM forward and reverse primer of
desired amplification product was added. 1 µl of ~200 ng/μl phenol/chloroform-purified K279a
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genomic DNA was added and 35.5 µl of water to bring the entire solution to 50 µl. The
extension temperature (step 4, table 2) was adjusted to 68°C for Phusion.
Gel Electrophoresis
To determine whether PCR products contained products of the appropriate size, the
products were examined by electrophoresis on 1% agarose gels that had been stained with
ethidium bromide. Gels were loaded with 5 µl of the desired PCR mix (with loading dye added
as necessary) or 2-log DNA ladder and then run at constant 100 volts. Duration varied between
30-60 minutes, depending on the size of the gel. The image of each gel was obtained after
exposure to ultraviolet light in a VersaDoc Model 4000 (Bio-Rad, Hercules, CA). PCR products
were compared to the 2 Log DNA ladder for size determination.
Modifications to basic PCR procedure
In many cases, extra bands indicating nonspecific amplification were observed. To rectify
this, the desired bands were gel purified using the QIAquick Gel Extraction Kit (Qiagen, Hilden,
Germany), and this purification product was used in a second round of amplification using
HotStar polymerase as described above. This methodology was only performed with HotStar
polymerase, since GoTaq green was only used for screening (the products never needed to be
isolated) and Phusion was ineffective for specific amplification of the desired products.
Gel extraction followed the manufacturer protocol, and began with excision of the DNA
fragment from the gel with a scalpel. The gel slice was weighed, and 3 volumes of Buffer QG
was added for 1 volume gel (100 mg gel was estimated to be roughly equivalent to 100 µl as per
kit instructions). This was incubated at 50°C for 10 minutes or until the gel dissolved completely.
To this 1 gel volume of isopropanol was added. This mixture was placed in the QIAquick Spin
Columns and centrifuged at 14,000 rpm in a tabletop centrifuge for 1 minute. The flowthrough
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was discarded. 500 µl of Buffer QG was added to this column and centrifuged again for 1 minute
at 14,000 rpm. The flowthrough was discarded again. 750 µl of Buffer PE was added, and
centrifugation was repeated. Again, flow through was discarded. The column was then
transferred to a new microcentrifuge tube. To elute the DNA, 50 µl of ddH 2 O was added and
centrifugation was repeated. The resulting mixture could be used again in subsequent PCR
reactions to amplify desired products.

Purification of pEX18Tc
The vector into which the PCR-amplified gene products were to be inserted for
interrupting the genes in S. maltophilia, pEX18Tc, is able to replicate in E. coli but not S.
maltophilia and provides tetracycline resistance(13). In order to have sufficient quantities of
pEX18Tc for cloning, it was first purified from DH5α E. coli using the Qiagen Spin Miniprep kit
using the manufacturer’s protocol (Qiagen, Hilden, Germany). The purified pEX18Tc was
quantified on a Nanodrop 2000 (Nanodrop, Wilmington, Delaware) by measuring absorbance at
260 nm.

Figure 2: Structure of the plasmid pEX18Tc used as a vector (13).
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Purifications and Restriction Enzyme Digestion
Once amplification of the desired PCR products had been confirmed with gel
electrophoresis, the DNA products and plasmid into which they were going to be inserted were
digested using restriction enzymes BamHI and EcoRI (NEB), both of which have unique
restriction sites in the multicloning locus that interrupts lacZα in pEX18Tc (Figure 2). Prior to
digestion, the amplification products were purified from the PCR mixes. This was done using
QIAquick PCR Purification Kit (Qiagen, Hilden, Germany) according to manufacturer
instructions.
The resulting mixture was analyzed on a Nanodrop 2000 (using ddH 2O as a blank) to
determine the concentration of purified gene products so that 1 μg of each of the amplification
products and 6 μg of pEX18Tc could be digested in the mixtures outlined in Table 3.
Table 3: Summary of prepared mixtures for restriction enzyme digest.
Digest

1:
rpfG

2:
Smlt_0184

3:
Smlt_0278

4:
Smlt_1432

5:
Smlt_1839

6:
Smlt_3567

7:
pEX18TC

2 µl

2 µl

2 µl

2 µl

2 µl

2 µl

4 µl

1 µl

1 µl

1 µl

1 µl

1 µl

1 µl

6 µl

EcoRI

1 µl

1 µl

1 µl

1 µl

1 µl

1 µl

6 µl

CIP

0

0

0

0

0

0

1 µl

DNA to
be
Digested
ddH2O

6.3 µl

6.5 µl

9.0 µl

9.9 µl

8.7 µl

7.4 µl

18.3 µl

9.7 µl

9.5 µl

7.0 µl

6.1 µl

7.3 µl

8.6 µl

4.7 µl

Total
volume

20 µl

20 µl

20 µl

20 µl

20 µl

20 µl

40 µl

10×
CutSmart
Buffer
BamHI

DNA to be digested was determined with absorbance at 260 nm with a Nanodrop (Thermo Fisher). Water
was added to each solution to bring to total solution to a total volume of 20 µl for digests 1-6, and 40 µL
for digest 7. CIP (calf intestinal phosphatase) was used only in digest 7 to prevent religation.

This mixture was incubated at 37°C for 1 hour. Afterwards, an additional 1 µl of BamHI
and EcoRI was added to digests 1-6. For digest 7, 3 µl of BamHI and EcoRI each were added as
12

well as 1 µl of CIP (a phosphatase which dephosphorylates DNA ends to prevent the plasmid
that is cut with a single restriction enzyme from ligating with itself). This mixture was allowed to
incubate for an additional hour at 37°C. The digests were then purified with Qiagen Spin
Miniprep kit (Qiagen) following the manufacturer’s protocol.

Ligation of inserts Into Vector
The previously prepared mixtures were then subjected to ligation. Six tubes were
prepared with 250 ng purified, digested pEX18Tc to which the appropriate digested insert was
added at a five-fold molar excess. To this mixture, 3 µl of 10× DNA ligase buffer and 1 µl of T4
DNA ligase was added. Sterile ddH 2O was added to bring the final volume of the ligation
mixture to 30 µl. As controls, mixtures were prepared using only cut pEX18Tc and ligase,
omitting the insert, and cut vector alone, both of which were supplemented with the required
water to bring the mixtures to 30 µl. All mixtures were incubated overnight at 16°C.

Preparation of competent E. coli DH5α cells
In order to transform the ligations into cells so that the resultant plasmids could be
replicated and stored, competent E. coli cells were prepared using the following steps:
400 µl of an overnight culture of E. coli strain DH5α was grown in lysogeny broth (LB).
This culture was incubated at 37°C on a roller drum for 1.5 hours to ensure exponential phase
growth.
After 1.5 hours, the tubes of inoculated broth were put on ice for 15 minutes. They were
then centrifuged at 14,000 rpm for two minutes at 4°C. The supernatant was discarded, and the
pellet was resuspended using 500 µl of ice cold 100 mM MgCl2 . This mixture was centrifuged at
14,000 rpm for two additional minutes at 4°C. The supernatant was discarded, and the pellets
were resuspended in 500 µl of 100 mM of CaCl 2. This mixture was left on ice for 30 minutes
13

before the cells were repelleted. The supernatant was discarded. The cells were resuspended in a
mixture of 100 µl 15% glycerol and 100 mM CaCl2 solution. This mixture was stored at -80°C
until needed for transformations.

Transformation of ligations into chemically competent E. coli
Chemically competent DH5α cells were thawed on ice. 100 µL of these cells was added
to each of 8 tubes containing the eight previously prepared ligation mixes and were vortexed on
high for 2-3 seconds. As a positive control, an additional transformation was made using only
undigested pEX18Tc plasmid. As a negative control, a transformation mixture was made without
a DNA template. These mixtures were incubated on ice for 10 minutes, then at 42°C for 1
minute, and back on ice for an additional 10 minutes. 1 ml of sterile LB was added to each
transformation, and the cells were then incubated at 37°C and approximately 300 rpm for 1 hour
to promote expression of the resistance markers on the plasmids. 100 µl of this solution was
plated on LB plates with Tet(10) (tetracycline, 10 μg/ml) and spread using glass beads. These 10
agar plates were incubated overnight at 37°C. Growth was assessed by examining number and
size of colonies that formed.
The transformed colonies were transferred onto fresh LB Tet(10) plates using sterile
toothpicks and allowed again to grow overnight. In the morning, select colonies (5 from each
ligation) were selected for use as templates in colony PCR reactions using the GoTaq green
procedure outlined above, substituting the template with select colonies. This was done in order
to identify colonies containing insert of the appropriate size. Positive controls were made using
K279a gDNA as the template, and a negative control was made substituting ddH2O for DNA
template.

14

The results of the PCR were used to identify colonies that contain the transformed
plasmid with the correct insert. Promising colonies were subject to plasmid purification (as
outlined above, for isolating pEX18Tc originally) to eventually be used in sequencing to confirm
that transformation occurred. Additionally, the same colonies were then prepared to conjugate
the plasmid from E. coli into S. maltophilia because identical sequence across the entire insert
was not deemed to be essential for single crossover insertional disruption of the desired genes
(Figure 1).

Conjugation from E. coli into S. maltophilia
In order to transfer the plasmid from E. coli into S. maltophilia¸ the helper strain E. coli
pRK2013 which allows interspecies conjugation(12) was used. E. coli DH5α containing the
appropriate plasmids were used to inoculate 5 mL of LB Tet(10). S. maltophilia K279a was
placed in 5 ml of LB broth containing no antibiotic. The helper strain of E. coli (pRK2013) was
placed in 5 ml of LB broth with kanamycin (50 μg/ml). These were incubated at 37°C and
approximately 300 rpm overnight.
Following overnight incubation, S. maltophilia K279a was heat shocked at 42°C for two
hours. 400 µl of heat-shocked K279a was mixed with 200 µl of donor E. coli (containing the
desired pEX18Tc derivative) and 200 µl of helper E. coli pRK2013. This mixture was spun at
1500 rpm for 1 minute. The supernatant was discarded and the cells were resuspended in 100 µl
of plain LB broth. This mixture was place on the mating plates (LB without antibiotics) and
incubated overnight at 37°C.
On the following day, the overnight mating growth was resuspended in 1 ml of drug-free
LB broth. 300 µl and 100 µl of this suspension were plated on agar plates containing Tet 20 and
irgasan 25 µg/ml. Tetracycline selects for bacteria containing pEX18Tc. Irgasan prevents E. coli
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growth but not S. maltophilia growth. Due to an increased generation time because of the high
concentrations of antibiotics used and the lower temperature, these plates were incubated for 3
days. Background growth was detected, and so suspected S. maltophilia colonies were isolated
using sterile toothpicks and struck for isolation on fresh plates with Tet 20 and irgasan 25.
Isolated transconjugants were expected to contain an interruption of the target gene. This
interruption would occur as a result of the single cross-over event that would occur between the
inserted sequence in pEX18Tc and the original insertion sequence on K279a’s genome.
Interruption would cause any products produced from transcription of the gene to be
nonfunctional, as both ends of the gene are incomplete (Figure 1).
To screen for the desired transconjugants, isolated colonies were subject to PCR using
GoTaq green procedure outlined above, with an increase in the elongation time (step 4, table 2)
to 10 minutes for each cycle. A second PCR was performed with HotStar (with the same increase
in the elongation time) because GoTaq Green has limited processivity. For these PCR reactions,
the template was colony matter from the isolated S. maltophilia transconjugant colonies. As a
positive control K279a genomic DNA was used as template.
A PCR was also performed using the GoTaq green procedure and primers for the
sequences on pEX18Tc immediately upstream and downstream of the multicloning locus. A
product from this PCR would indicate that there was intact plasmid in the S. maltophilia cells (no
insertion into the desired sequence). The normal PCR temperature cycling was used (Table 2),
and the gel was run with normal conditions.

Growth of S. maltophilia with P. aeruginosa.
C3719, a cystic fibrosis clinical isolate of P. aeruginosa for which the genome sequence
is known, was used to assay the growth with the conjugated S. maltophilia colonies. C3719 was
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prepared from freezer stock and struck for isolation. The colonies of both C3719 and each of the
transconjugants were inoculated into LB broth and grown overnight at 37°C. The following
morning, 1 μl of the inoculated broth was spotted on LB agar plates without antibiotics. Colonies
to be tested for effects on growth were placed 1cm apart and each pairing was assayed in
triplicate. For each of the conjugations, several controls were prepared. One control involved
growing two C3719 colonies together, another with C3719 next to wild-type K279a, and finally
a third control was prepared by growing the transconjugant S. maltophilia colony with wild-type
K279a.
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Results
PCR Optimization
PCR followed by gel electrophoresis was used to identify the conditions leading to
optimal amplification of the desired products. Initially, GoTaq green was used to verify that the
primers could be used to amplify the desired gene products (Figure 3).

Figure 3: Initial GoTaq Green PCR. L = 2 Log DNA ladder. PCR1:
Smlt_1839, 2: Smlt_3567, 3: Smlt_0278, 4: Smlt_1432, 5: rpfG, 6:
Smlt_0184. Desired amplification events appear successful with the
given primers and GoTaq Green.
Due to GoTaq green’s low fidelity, it was not used for to amplify products for ligation.
Both HotStar and Phusion are described by their manufacturers as having higher fidelity than
GoTaq Green, although their amplification product yield can sometimes be less robust than
GoTaq Green.
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Initially, HotStar was only able to successfully amplify Smlt_0184, Smlt_1432, and
Smlt_1839 (Figure 4).

Figure 4: HotStar PCR. L = 2 Log DNA ladder. PCR1: rpfG, 2: Smlt_0184,
3: Smlt_0278, 4: Smlt_1432, 5: Smlt_1839, 6: Smlt_3567. Figure shows
successful amplification of Smlt_0184, Smlt_1432, and Smlt_1839 with
minimal extra bands.
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Figure 5: Phusion PCR. L = 2 Log DNA ladder. PCR1: Smlt_0278.
PCR 2: Smlt_3567.
Amplification of Smlt_0278 and Smlt_3567 was then attempted with Phusion, but only
faint bands (of many sizes in each reaction) were produced (Figure 5).
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Figure 6: Repeat HotStar PCR using previous PCR mixes as templates. L = 2 log
ladder. Reaction 1 corresponds to rpfG. Reaction 2 corresponds to Smlt_0278.
Reaction 3 corresponds to Smlt_3567.
Due to the ineffectiveness of Phusion, the amplification of rpfG, Smlt_0278, and
Smlt_3567 was repeated with HotStar, using purified PCR products from previous attempts that
showed promising results. These reactions resulted in strong bands of rpfG products in both
attempts. While reactions with Smlt_0278 and Smlt_3567 produced bands of the desired size,
they also produced a significant amount of additional bands of undesired products (Figure 6).
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Figure 7: Repeat HotStar PCR using previous PCR mixes as
templates. L = 2 log ladder. Reaction 1 corresponds to rpfG.
Reaction 2 corresponds to Smlt_0278. Reaction 3
corresponds to Smlt_3567.
Using gel purified products of appropriately sized bands of PCR amplification of
Smlt_0278 and Smlt_3567, PCR was repeated with HotStar resulting in successful amplification
(Figure 7).

Purifications, Restriction Enzyme Digestion and Ligations
Once all 6 gene inserts had been amplified, they could be digested in preparation for
ligation into the vector. After digestion, the digests were purified and the concentrations of the
resultant products were determined to determine the proper volume to achieve 5 fold-molar
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excess of the amplified insert with pEX18 for digestion. Ligations were then performed and
prepared for transformation.
Table 4: Concentrations of purified digest products
Digest

Concentration (ng/nL)

1 – rpfG
2 – Smlt_0184

18.9
30.2

3 – Smlt_0278
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4 – Smlt_1432
5 – Smlt_1839

35.9
37.9

6 – Smlt_3657
7 – pEX18Tc

29
15.6

Transformation of ligations into chemically competent E. coli
The ligations were then transformed into chemically competent DH5α cells.
Transformants were plated on LB with tetracycline and incubated. Assessment of the growth is
show in Table 5.
Table 5: Colony densities from plated E. coli on Tet(10) plates post transformation.
Transformation
DNA
CFUs/mL
1
rpfG
220
2
Smlt_0184
1110
3
Smlt_0278
910
4
Smlt_1432
2160
5
Smlt_1839
4920
6
Smlt_3567
2560
7
No insert
80
8
No ligase, no insert
0
9
Positive control: pEX18Tc
Too many to count
10
No template
0
Results show that transformation proceeded as expected, as the negative controls (8 and 10) did
not show any growth and the remainder did grow as was expected.
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These colonies were transferred onto fresh LB plates and allowed to grow overnight. Five
colonies from each ligation examined by colony PCR to identify colonies with insert of the
desired size (Figure 8).

Figure 8: cPCR (colony PCR) of five colonies from each of the 6 transformations.
Reactions 11-17 represent colonies transformed with rpfG. 21-27: Smlt_0184.
31-37: Smlt_0278. 41-47: Smlt_1432. 51-57 Smlt_1839. 61-67: Smlt_3567. 11-15,
21-25, 31-35, 41-45, 51-55, and 61-65 represent the 5 colony isolates used as
templates. Reactions 16, 26, 36, 46, 56, and 66 represent positive controls for each
reaction where the template was 1 µl of K279a DNA. Reactions 17, 27, 37, 47, 57,
and 67 were negative controls, where 1 µl ddH 2 O was used as a template. The
negative controls show bands corresponding to the primers that were added.
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Figure 9: Repeat cPCR (colony PCR) of five colonies from 4 of the transformations.
Reactions 31-37 represent Smlt_0278. 41-47: Smlt_1432. 51-57 Smlt_1839. 61-67:
Smlt_3567. 31-35, 41-45, 51-55, and 61-65 represent the 5 colony isolates
used as templates. Reactions 36, 46, 56, and 66 represent positive controls for each
reaction where the template was 1 µl of K279a DNA. Reactions 37, 47, 57, and 67
were negative controls, where 1 µl ddH2O was used as a template. The negative
controls show bands corresponding to the primers that were added.
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Because PCR on colonies from transformations 3-6 failed to identify colonies producing
a single band of the desired size, the PCRs were repeated using different colonies (Figure
9).These PCR reactions (Figure 8 and 9) identified for two rpfG, two Smlt_0184, four
Smlt_0278, three Smlt_1432, two Smlt_1839, and two Smlt_3657 colonies that produced bands
that appeared to be the appropriate size. Plasmids from these colonies were then purified and
used as templates in subsequent PCR reactions (Figure 10).

Figure 10: cPCR post plasmid purification. Reactions 11-14 represent rpfG. 21, 22,
26, 27: Smlt_0184. 31-34: Smlt_0278. 41-45: Smlt_1432. 51-54: Smlt_1839. 6164: Smlt_3657. 13, 26, 33, 44, 53, and 63 represent positive controls (pEX18Tc
used as a template). 14, 27, 34, 45, 54, and 64 represent negative controls,
where ddH2O was used as a template. The negative controls show bands
corresponding to the primers that were added.

These results identified the best candidates to be used for conjugation into S. maltophilia
(11, 21, 22, 41, 42, 51, 52, 61, and 62). There were no reactions for Smlt_0278 that produced
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results sufficient to proceed with conjugation (additional bands, bands in the negative control),
so that reaction was left out for the remainder of experimentation.

Conjugation from E. coli into S. maltophilia
The previously identified nine colonies were used for conjugation. All of the
conjugations into S. maltophilia had at least 30 colonies after 2 days incubation at room
temperature. After 3 days there was background growth on all of the plates, so larger colonies
were transferred onto fresh LB Tet (20) Irg (25) plates using sterile toothpicks and grown

Figure 11: cPCR of isolate S. maltophilia colonies after conjugation. L corresponds to
two log ladder used for size identification. Reaction 11-14 are four colonies for the
first conjugation rpfG. 21-24: conjugation 2, 31-34 conjugation 3, both corresponding
to Smlt_0184. 41-44: conjugation 4, 51-54: conjugation 5, both corresponding to
Smlt_1432. 61-64: conjugation 6, 71-74: conjugation 7, both corresponding to
Smlt_1839. 81-84: conjugation 8, 91-94: conjugation 9, both corresponding to
Smlt_3657. 15, 35, 55, 75, and 95 correspond to positive controls in which wild-type
K279a was added in place of transconjugant colonies. 16, 36, 56, 76, and 96
correspond to controls in which ddH2O was added as a template.
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overnight at 37°C. These were then streaked for isolation and used in another PCR to assay for
desired products (Figure 11).
The products after conjugation were expected to include bands of the original insert size
as well as bands approximately 6 kb larger than the original genes because they should include
the entire plasmid integrated into the gene (Figure 1). Findings depicted in Figure 11 suggest that
conjugation may not have occurred in the desired location, but this is not entirely conclusive
because GoTaq Green often is not processive enough to amplify more than 2000 bp.

Figure 12: Repeat cPCR of transconjugant colonies using pEX18Tc primers. L = log
2 ladder for size comparison. Conjugation 1(rpfG) was plated in lanes 1a and 1b,
with two different isolated colonies. Lane 2 and 3 are colonies from conjugations 2
and 3 (Smlt_0184). 4/5: Conjugations 4 and 5 (Smlt_1432). 6/7: Conjugations 6
and 7 (Smlt_1839). 8/9: Conjugations 8 and 9 (Smlt_3657).
The PCR was repeated with only 2 colonies representing each gene to be interrupted with
primers for pEX18Tc (Figure 12). These PCR reactions should show a product only when the
plasmid is present without recombination at the gene of interest. If the cloned insert is intact the
PCR will give a product that is the size of the insert as the primers will amplify across the insert.
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If the insert has recombined into the chromosome through single crossover, the primers will be
pointing out and would lead to amplification of the entire genome except the plasmid sequence
to produce a band, and this is extremely unlikely to happen in the extension time allotted. The 9
transconjugant colonies were renamed (Table 6). K279aΔrpfG#1, K279aΔsmlt0184#2,
K279aΔsmlt1432#2, K279aΔsmlt1839#1, and K279aΔsmlt3657#2 lacked bands the size of the
inserts and were assumed to represent the appropriate construct.
Table 6: New naming scheme for transconjugant colonies.
Insert
Conjugation Original isolate colony # New name
rpfG
1
11
K279aΔrpfG#1
rpfG
1
12
K279aΔrpfG#2
Smlt_0184 2
21
K279aΔsmlt0184#1
Smlt_0184 3
41
K279aΔsmlt0184#2
Smlt_1432 4
1
K279aΔsmlt1432#1
Smlt_1432 5
21
K279aΔsmlt1432#2
Smlt_1839 6
41
K279aΔsmlt1839#1
Smlt_1839 7
1
K279aΔsmlt1839#2
Smlt_3657 8
23
K279aΔsmlt3657#1
Smlt_3657 9
41
K279aΔsmlt3657#2

Growth of S. maltophilia with P. aeruginosa
Co-growth of P. aeruginosa and one isolate of each knockout strain was assayed.
Transconjugants were chosen and individually plated 1 cm away from P. aeruginosa C3719 in
triplicate. The plates were incubated overnight at 37°C. Growth was examined for qualitative
changes in compared to P. aeruginosa and wild type K279a (Figure 13). There were little to no
changes.
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K279a
Transconjugant

3

C3719

C3719

B
C3719

K279a
Wildtype

K279a
Wildtype

C
C3719

K279a
Transconjugant

C3719

D
C3719

Figure 13: Growth testing of K279a (S. maltophilia) with C3719 (P. aeruginosa). The table depicts the lay-out for
each of the growth plates as depicted in this figure. Columns C and D are controls, while A and B are the tests.
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A
K279a
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Discussion
PCR optimization
Out of the three polymerases examined for amplification of the desired gene products
(GoTaq Green, HotStar, and Phusion), HotStar appeared to be the best choice due to the balance
of product yield and polymerase fidelity. It produced consistent results, although it occasionally
required gel purification to isolate the desired amplification products.
GoTaq green was a useful polymerase, as it was an efficient means of running PCRs
(low cost, less complicated mix) and it consistently showed bands of the desired size. For
amplifications resulting in products to be used for cloning it was not used due to its low fidelity.
However, it was used extensively to determine whether constructs had the appropriate size.
Transformation of Ligations into Chemically Competent E. coli
E. coli DH5α was chosen as the initial species for transformation as it provided an easy,
efficient way to replicate the intact plasmid. The transformed colonies that were produced were
easy to handle; they could be frozen (for long term storage) and readily grew on simple LB agar
plates and in liquid broths as needed. A large stock was easily produced and then used for
conjugation.
The results of the PCRs for transformed colonies of E. coli (Figure 8, Figure 9, and
Figure 10) only occasionally showed evidence of successful transformation of the ligated
plasmid. In many cases, there were additional unexpected products. Explanations for this
phenomenon include insertion of multiple copies of the cloned sequence into the plasmid in
tandem or nonspecific binding of the primers to E. coli genomic DNA. As a result of the
additional bands, several attempts were required to find colonies that contained the desired
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inserts. Successful insertion of Smlt_0278 was not identified after multiple screening attempts, so
this gene was not included in conjugations and growth assays
Conjugation and Growth testing
Cloning produced plasmids in E. coli that appear to have the desired sequence for five of
the desired genes. These plasmids were conjugated into S. maltophilia K279a resulting in
transconjugants with the desired antibiotic resistances from each plasmid. However, there
appeared to be conflicting evidence as to whether or not the conjugation and recombination
occurred as intended. pEX18Tc lacks a S. maltophilia origin of replication and is therefore
unable to replicate(13). Additionally, without the tetracycline resistance gene from pEX18Tc
plasmid, the K279a strain of S. maltophilia cannot grow on tetracycline present on the selective
plates. E. coli cannot grow in the presence of irgasan. This means that only S. maltophilia that
has acquired tetracycline resistance (most likely from the plasmid) and incorporated the
associated genes into its chromosome can grow on the irgasan and Tetracycline. Furthermore,
the colonies appeared in coloration more like S. maltophilia than E. coli leading to the
assumption that they are not E. coli colonies that acquired irgasan resistance from S. maltophilia.
The growth of S. maltophilia colonies on the irgasan and Tetracycline plates is evidence
that the transformation and recombination was successful. However, two rounds of PCR (with
GoTaq Green and HotStar) did not show strong evidence of recombination events. Due to the
interruption of the gene, the PCR should result in bands of two different sizes: one the size of the
gene and the other 6.2 kB larger (Figure 1). Instead, the products of amplification, for the most
part, were the same size as the original gene.
One explanation for this event could be that the recombination did not result in the gene
being interrupted. This could occur if there was another region on pEX18Tc that contained a
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similarity the K279a genome for which recombination could occur. In this case, the plasmid
would recombine and confer tetracycline resistance to the bacteria without knocking out the
gene, and the resulting PCR would only amplify the original gene.
It is possible that all the colonies we isolated were spontaneous tetracycline mutants, but
the probability of that happening is quite small (and the negative controls did not show any
growth). It is also possible that unlike our expectations pEX18Tc is able to replicate in S.
maltophilia. The actual requirements for replication in S. maltophilia are unknown, but
pEX18Tc is only known to contain an origin of replication for E. coli, and S. maltophilia is much
more closely evolutionarily related to P. aeruginosa, where pEX18Tc cannot replicate, than it is
to E. coli. Recent unpublished work in the lab of Dr. Deborah Yoder-Himes suggests that
pEX18Tc is unable to replicate in K279a. The most likely explanation, however, is that the
smaller PCR product is preferentially made as large products can be used as templates for small
products in subsequent cycles but small products cannot be templates to amplify the large
product (Figure 1). As such, this PCR was an inconclusive test of the structure of the
transconjugants.
Even if the conjugation and recombination resulted in the desired construct and the gene
was interrupted, significant difference in the growth of S. maltophilia in the presence of P.
aeruginosa was not observed in any of the trials. Direct side-by-side growth showed no
difference from the control (Figure 13). This finding suggests that the insertional interruption had
no effects on growth in this in vitro setting. However, this may or may not relate to how these
transconjugants would behave in vivo settings. Significant signaling may occur when the two
bacteria grow together, or only in models that place the two species in similar environments as
found in the human respiratory tract. Further study could be done to determine if any of these
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transconjugants have significant effect on growth in models that promote biofilm formation and
settings that mimic the environment found in cystic fibrosis patients. Additionally, it is possible
that 1 cm is too far apart for effectors released by one of these species to impact growth of the
other species. Bacteria are in much closer proximity in biofilm habitats.
In conclusion, it is uncertain at this time if insertional interruption was successful.
However, the E. coli transformants have shown that they have successfully taken up plasmids
with the desired inserts. The purified plasmids from these are awaiting sequencing at this time.
Experiments proceeded without sequencing of the inserts because, since they would be used to
interrupt the respective gene, 100% identity, while useful, was not deemed to be essential.
Assuming sequencing confirms the correct insertion, these colonies can still be used to reattempt
insertion interruption with S. maltophilia and then subsequent growth testing with P. aeruginosa.
Additionally, more models of growth that more accurately mimic the biofilm environment
created between these two species in cystic fibrosis patients could be tested with both current
existing and new transconjugant strains of S. maltophilia. Finally, it is possible that additional
signaling receptors have yet to be identified that play the most significant role in the growth
interplay between S. maltophilia and P. aeruginosa in biofilms in the cystic fibrosis lung.

34

References
1. Ciofu, O., Hansen, C., & Hoiby, N. (2013). Respiratory Bacterial Infections in Cystic Fibrosis. Current Opinion in
Pulmonary Medicine Curr Opin Pulm Med, 13(3), 251-258. doi:10.1097/MCP.0b013e32835fafc
2. Goncalves-Vidigal, P., Grosse-Onnebrink, J., Mellies, U., Buer, J., Rath, P., & Steinmann, J. (2011).
Stenotrophomonas maltophilia in cystic fibrosis: Improved detection by the use of selective agar and evaluation of
antimicrobial resistance. Journal of Cystic Fibrosis, 10(6), 422-427. doi:10.1016/j.jcf.2011.06.010
3. Looney, W., Narita, M., & Mühlemann, K. (2009). Stenotrophomonas maltophilia: An emerging opportunist
human pathogen. The Lancet Infectious Diseases, 9(5), 312-323.
doi:10.1016/S1473-3099(09)70083-0
4. Pompilio, A., Crocetta, V., Confalone, P., Nicoletti, M., Petrucca, A., Guarnieri, S., . . . Bonaventura, G. (2010).
Adhesion to and biofilm formation on IB3-1 bronchial cells by
Stenotrophomonas maltophilia isolates from cystic fibrosis patients. BMC Microbiology
BMC Microbiol, 10, 102-116. doi:10.1186/1471-2180-10-102
5. Pompilio, A., Pomponio, S., Crocetta, V., Gherardi, G., Verginelli, F., Fiscarelli, E., . . . Bonaventura, G. (2011).
Phenotypic and genotypic characterization of Stenotrophomonas maltophilia isolates from patients with cystic
fibrosis: Genome diversity, biofilm formation, and virulence. BMC Microbiology BMC Microbiol, 11(1), 159-175.
doi:10.1186/1471-2180-11-159
6. Pompilio, A., Ciavardelli, D., Crocetta, V., Consalvo, A., Zappacosta, R., Ilio, C., & Bonaventura, G. (2014).
Stenotrophomonas maltophilia Virulence and Specific
Variations in Trace Elements during Acute Lung Infection: Implications in Cystic
Fibrosis. PLoS ONE, 9(2), 1-17. doi:10.1371/journal.pone.0088769
7. Rudkjøbing, V., Thomsen, T., Alhede, M., Kragh, K., Nielsen, P., Johansen, U., . . . Bjarnsholt, T. (2012). The
microorganisms in chronically infected end-stage and non-end-stage cystic fibrosis patients. FEMS Immunology &
Medical Microbiology FEMS Immunol Med Microbiol, 65(2), 236-244. doi:10.1111/j.1574-695X.2011.00925.x
8. Samonis, G., Karageorgopoulos, D., Maraki, S., Levis, P., Dimopoulou, D.,
Spernovasilis, N., . . . Falagas, M. (2012). Stenotrophomonas maltophilia Infections in a
General Hospital: Patient Characteristics, Antimicrobial Susceptibility, and Treatment
Outcome. PLoS ONE, 7(5), 1-7. doi:10.1371/journal.pone.0037375
9. Tümmler, B., & Kiewitz, C. (1999). Cystic fibrosis: An inherited susceptibility to bacterial respiratory infections.
Molecular Medicine Today, 5(8), 351-358.
10. Vrankrijker, A., Wolfs, T., & Ent, C. (2010). Challenging and emerging pathogens in cystic fibrosis. Paediatric
Respiratory Reviews, 11(4), 246-254.
doi:10.1016/j.prrv.2010.07.003
11. Crossman, L., Gould, V., Dow, J., Vernikos, G., . . . (2008). The complete genome, comparative and functional
analysis of Stenotrophomonas maltophilia reveals an organism heavily shielded by drug resistance determinants.
Genome Biology, 9:R74. doi:10.1186/gb-2008-9-4r74
12. Ditta, G., Stanfield, S., Corbin, D., Helinski, D. (1980). Broad host range DNA cloning system for Gramnegative bacteria: Construction of a gene bank of Rhizobium meliti. Proceedings of the National Academy of
Sciences of the United States of America 77(12), 7347-7351.
13. Hoang T.T., Karkhoff-Schweizer R.R., Kutchma A.J., Schweizer H.P.. (1998) A broad-host-range Flp-FRT
recombination system for site-specific excision of chromosomally-located DNA sequences: application for isolation
of unmarked Pseudomonas aeruginosa mutants. Gene 28;212(1): 77-8
14. Das, M., Sandhu, P., Gupta, P., Rudrapaul, P. ... (2016) “Attenuation of Pseudomonas aeruginosa biofilm
formation by Vitexin: A combinatorial study with azithromycin and gentamicin.” Scientific Reports 6, Article
number: 23347
15. Lasarre, B., and M. J. Federle. "Exploiting Quorum Sensing To Confuse Bacterial Pathogens." Microbiology and
Molecular Biology Reviews 77.1 (2013): 73-111.
16. Kievit, T. R. De. "Quorum Sensing in Pseudomonas Aeruginosa Biofilms."Environmental Microbiology 11.2
(2009): 279-88.

35

